About
Joined AdBio in 2017 with more than 17 years in biotechnology company management. Co-founder of four companies in AdBio portfolio. CEO of Alderaan Biotechnology and Yukin Therapeutics. Previously senior VP at TxCell (acquired by Sangamo), developing cell therapies for chronic inflammatory diseases. 12 years at TxCell managing cell therapy research and regulatory affairs.
Sign up to see Arnaud Foussat's full profile
Access investment thesis, focus areas, bio, and contact details for Arnaud Foussat and 22,000+ other VC professionals.
AdBio Partners
Paris, FR